Equillium Inc

Research Equillium Inc (EQ) on Bullrun: market cap USD 194.74M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerEQ
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 194.74M
• Financial periodFY2025
• Net income-USD 22.40M
• Free cash flow-USD 22.79M

Valuation Snapshot

latest market cap is USD 194.74M.

About Equillium Inc

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases.

Frequently asked questions

What is Equillium Inc's market cap?

Equillium Inc's market capitalization is USD 194.74M.

What does Equillium Inc do?

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States.